Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von willebrand factor concentration and cardiovascular risk

Circulation: Cardiovascular Genetics

Volumn 3, Issue 6, 2010, Pages 507-512

  Van Loon, Janine E ^a   Leebeek, Frank W G ^a   Deckers, Jaap W ^a   Dippel, Diederik W J ^a   Poldermans, Don ^a   Strachan, David P ^b   Tang, Weihong ^c   O'Donnell, Christopher J ^d,e   Smith, Nicholas L ^f   De Maat, Moniek P M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiovascular diseases; Genetics; STX2; STXBP5; Von Willebrand factor

Indexed keywords

SYNTAXIN 2; SYNTAXIN BINDING PROTEIN 5; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; ALLELE; ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; FEMALE; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; COLLAGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; R-SNARE PROTEINS; RISK; SYNTAXIN 1; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 79952813198     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.110.957407     Document Type: Article

References (18)

1. Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997;34:255-265. (Pubitemid 27241568)
2. Martinelli I. von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Semin Hematol. 2005;42:49-55. (Pubitemid 40127270)
3. Bladbjerg EM, de Maat MP, Christensen K, Bathum L, Jespersen J, Hjelmborg J. Genetic influence on thrombotic risk markers in the elderly: a Danish twin study. J Thromb Haemost. 2006;4:599-607.
4. de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ. The genetics of haemostasis: a twin study. Lancet. 2001;357:101-105. (Pubitemid 32094912)
5. Ruggeri ZM, Ware J. von Willebrand factor. FASEB J. 1993;7:308-316. (Pubitemid 23067781)
6. Ruggeri ZM. Old concepts and new developments in the study of platelet aggregation. J Clin Invest. 2000;105:699-701. (Pubitemid 30164105)
7. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell. 1986;46:185-190. (Pubitemid 16031685)
8. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217-246.
9. Burgess TL, Kelly RB. Constitutive and regulated secretion of proteins. Annu Rev Cell Biol. 1987;3:243-293.
10. Pinsky DJ, Naka Y, Liao H, Oz MC, Wagner DD, Mayadas TN, Johnson RC, Hynes RO, Heath M, Lawson CA, Stern DM. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies: a mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest. 1996;97:493-500.
11. Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008;117: 1449-1459. (Pubitemid 351501497)
12. Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, Soranzo N, Hayward C, Rudan I, Sabater-Lleal M, Bis JC, de Maat MP, Rumley A, Kong X, Yang Q, Williams FM, Vitart V, Campbell H, Malarstig A, Wiggins KL, Van Duijn CM, McArdle WL, Pankow JS, Johnson AD, Silveira A, McKnight B, Uitterlinden AG, Aleksic N, Meigs JB, Peters A, Koenig W, Cushman M, Kathiresan S, Rotter JI, Bovill EG, Hofman A, Boerwinkle E, Tofler GH, Peden JF, Psaty BM, Leebeek F, Folsom AR, Larson MG, Spector TD, Wright AF, Wilson JF, Hamsten A, Lumley T, Witteman JC, Tang W, O'Donnell CJ. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121:1382-1392.
13. Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med. 2005;15:302-308. (Pubitemid 41613876)
14. Drenos F, Miller GJ, Humphries SE. Increase of plasma fibrinogen levels and variability with age in a sample of middle aged healthy men. Ann Hum Genet. 2007;71:43-53. (Pubitemid 44857681)
15. de Bruijne EL, Gils A, Guimaraes AH, Dippel DW, Deckers JW, van den Meiracker AH, Poldermans D, Rijken DC, Declerck PJ, de Maat MP, Leebeek FW. The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study. J Thromb Haemost. 2009;7:919-927.
16. Bongers TN, de Bruijne EL, Dippel DW, de Jong AJ, Deckers JW, Poldermans D, de Maat MP, Leebeek FW. Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients. Atherosclerosis. 2009;207:250-254.
17. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
18. Goligorsky MS, Patschan D, Kuo MC. Weibel-Palade bodies: sentinels of acute stress. Nat Rev Nephrol. 2009;5:423-426.